跳至主要内容
临床试验/KCT0002252
KCT0002252招募中未知

Study for smoking effect on airway innate immune system and microbiome of asthmatic patients

Chung-Ang Univerisity Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 70(Year)(—)
性别
All

入选标准

  • Asthma (Any of the following criteria)?
  • -Bronchodilator response (+): FEV1(Forced Expiratory Volume in the first second) increase >12% and 200 mL
  • -FEV1 (forced expiratory volume 1) variation (>12% and 200 ml) with or without treatment >12% and 200 mL
  • -Airway hyperresponsiveness (+) to methacholine or mannitol provocation

排除标准

  • 1. Severe medical condition (life expectancy <3 years) and current cancer 2. Severe psychiatric diseases 3. Other active airway or pulmonary (tuberculosis etc) 4. Recent exacerbation (within 3 months) 5. =40 Pack Year smoker in order to exclude COPD 6. Usage of drugs below 1 month ?:Antibiotics, antifungal agents, antiviral repellents Steroids: oral, intravenous, intramuscular that can activate inhibit the immune system: cytokines, methotrexate, anticancer drug) 7. Food: probiotics, prebiotics>

研究者

发起方
Chung-Ang Univerisity Hospital

相似试验